Phyton Biotech LLC

Phyton Biotech, a division of DFB Pharmaceuticals founded in 1990, is the world’s largest producer of high-quality paclitaxel and docetaxel using Plant Cell Fermentation technology. It offers integrated contract development and commercial manufacturing services from feasibility to production for pharmaceutical, cosmetic, agricultural, and food industries. Facilities in Germany and Canada comply with international GMP requirements and have been inspected by multiple regulatory agencies. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.